801 results on '"Mandel, Philipp"'
Search Results
302. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy
303. PD51-04 THE IMPACT OF ANXIETY AND DEPRESSION ON FUNCTIONAL OUTCOME IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY
304. MP97-14 FUNCTIONAL OUTCOME OF RADICAL PROSTATECTOMY AFTER REPEAT BIOPSY
305. PD10-04 FUNCTIONAL OUTCOMES AND QUALITY OF LIFE AFTER RADICAL PROSTATECTOMY: PATIENT REPORTED OUTCOMES OF A TERTIARY HIGH-VOLUME CENTER
306. Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer
307. Defining Renal Masses: Comprehensive Comparison of RENAL, PADUA, NePhRO, and C-Index Score
308. Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma
309. Tumor size and invasiveness matters for partial nephrectomy: External validation and modification of the arterial based complexity score
310. The Impact of Repeat Prostate Biopsies on Oncologic, Pathological and Perioperative Outcomes after Radical Prostatectomy
311. Public education, accountability, and yardstick competition in a federal system
312. Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of Recurrence
313. Cumulative instructional time and student achievement.
314. Risk of Biochemical Recurrence and Metastasis in Prostate Cancer Patients Treated with Radical Prostatectomy After a 10-year Disease-free Interval, on behalf of the EAU-YAU Prostate Cancer Working Group
315. Prostate-specific Antigen Nadir and Cancer-Control Outcomes in Real-world Apalutamide-treated Metastatic Hormone-Sensitive Prostate Cancer Patients: A Single-Center Analysis
316. Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study
317. Influence of Tumor Characteristics and Time to Metastatic Disease on Oncological Outcomes in Metachronous Metastatic Prostate Cancer Patients
318. Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all Stages
319. Formation of oxidative stress markers in DNA and RNA after treatment with aldosterone and angiotensin II in vitro and in vivo
320. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus
321. Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still Out
322. Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy
323. The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate Cancer
324. MP80-11 TUMOR CHARACTERISTICS, ONCOLOGICAL AND OVERALL OUTCOME AFTER RADICAL PROSTATECTOMY IN MEN 75 YEARS AND OLDER
325. Nerve-sparing Surgery Technique, Not the Preservation of the Neurovascular Bundles, Leads to Improved Long-term Continence Rates After Radical Prostatectomy
326. MP69-03 ASSOCIATION BETWEEN LYMPH NODE COUNTS AND ONCOLOGICAL OUTCOMES IN LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS
327. MP80-17 LONG-TERM ONCOLOGICAL OUTCOMES IN PATIENTS WITH PATHOLOGIC GLEASON 3+3 SCORE AT RADICAL PROSTATECTOMY
328. PD37-10 LONG-TERM ONCOLOGICAL OUTCOMES IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
329. MP57-06 RADICAL PROSTATECTOMY AFTER REPEAT BIOPSY: ONCOLOGICAL AND PERIOPERATIVE OUTCOME
330. Impact of surgeon-defined capsular incision during radical prostatectomy on biochemical recurrence rates
331. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer
332. Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy
333. Essays on Education and Other Human Capital Related Policies
334. Total instructional time exposure and student achievement: An extreme bounds analysis based on German state-level variation
335. External Validation of the CAPRA-S Score to Predict Biochemical Recurrence, Metastasis and Mortality after Radical Prostatectomy in a European Cohort
336. Public Education, Accountability, and Yardstick Competition in a Federal System
337. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria
338. The effect of age on functional outcomes after radical prostatectomy
339. Surgical learning curve for open radical prostatectomy: Is there an end to the learning curve?
340. Impact of Synchronous Metastasis Distribution on Cancer Specific Survival in Renal Cell Carcinoma after Radical Nephrectomy with Tumor Thrombectomy
341. Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer after Radical Prostatectomy
342. Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without blood pressure increase.
343. Interrupted versus continuous suturing for vesicourethral anastomosis during radical prostatectomy: protocol for a systematic review and meta-analysis.
344. Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.
345. Erratum: Apalutamid bei Patienten mit einem Hochrisiko-M0CRPC: Daten der Zulassungsstudie SPARTAN und erste Erfahrungen aus einem Härtefallprogramm.
346. Oxidative DNA Damage in Kidneys and Heart of Hypertensive Mice Is Prevented by Blocking Angiotensin II and Aldosterone Receptors
347. Extent of lymph node dissection and recurrence-free survival after radical cystectomy: A meta-analysis
348. EORTC Progression Score Identifies Patients at High Risk of Cancer-Specific Mortality After Radical Cystectomy for Secondary Muscle-Invasive Bladder Cancer
349. MP30-13 IMPACT OF MICROSCOPIC VEIN INVASION ON CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND TUMOR THROMBUS
350. MP57-11 DOES THE USE OF CARDIOPULMONARY BY-PASS (CPB) IMPACT SURVIVAL IN PATIENTS UNDERGOING NEPHRECTOMY/LEVEL III-IV TUMOR THROMBECTOMY? A MULTI-INSTITUTIONAL ANALYSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.